• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M006175263010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Urinary Tract Infection (2120); Burning Sensation (2146)
Event Date 03/21/2023
Event Type  Injury  
Manufacturer Narrative
The exact date of the event is unknown.The provided event date, (b)(6) 2023, was chosen as a best estimate based on the date that the manufacturer became aware of the event, (b)(6) 2023.Imdrf patient code e1310 captures the reportable event of urinary tract infection.Imdrf impact code f23 captures he reportable event of unexpected medical intervention.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was used during a urology stent procedure in the kidney on an unspecified date.Post procedure, the patient experienced burning urination and a bladder infection.An early, unplanned stent removal procedure was performed, on (b)(6) 2023, to explant the stent.Another device of the same model was implanted and used to complete the procedure.There were no medication or treatment given to the patient for the burning urination and bladder infection.The patient's condition was reported as stable, and the event was noted to have been resolved approximately one month after stent removal.
 
Manufacturer Narrative
Blocks d4 (lot number and expiration date) and h4 (device manufacture date) were updated based on the batch/lot number of the returned product.Block b3: the exact date of the event is unknown.The provided event date, (b)(6) 2023, was chosen as a best estimate based on the date that the manufacturer became aware of the event, (b)(6) 2023.Block h6: imdrf patient code e1310 captures the reportable event of urinary tract infection.Imdrf impact code f23 captures he reportable event of unexpected medical intervention.Block h10: the returned percuflex plus ureteral stent was analyzed, and a visual evaluation noted that the stent and the coil were in good condition and no damage was observed on the device.There was discoloration (blackened color) noted along the stent as part of the procedure.A photo of the device was also provided and showed no damage.A functional test was performed and a use of mandrel of 0.039" was used and passed through the stent successfully with no resistance.The "infection, urinary tract" reported is a known adverse event associated with the use of the device and it is noted within the instructions for use (ifu) and is known and documented in the labeling.Therefore, the most probable cause of the reported event is known inherent risk of the device.Based on a previous study for different ureteral stents and all the gathered information, the stent discoloration is caused by reaction of sulfide in urine with bismuth bicarbonate in the stent to produce bismuth sulfide.It is a non-harmful/cosmetic and does not increase stent-associated complications during use or its functionality.Therefore, no problem detected is selected as the most probable root cause for the complaint since there were no failures encountered in the device and no known problem was reported.
 
Event Description
It was reported to boston scientific corporation that a percuflex plus ureteral stent was used during a urology stent procedure in the kidney on an unspecified date.Post procedure, the patient experienced burning urination and a bladder infection.An early, unplanned stent removal procedure was performed, on (b)(6) 2023, to explant the stent.Another device of the same model was implanted and used to complete the procedure.There were no medication or treatment given to the patient for the burning urination and bladder infection.The patient's condition was reported as stable, and the event was noted to have been resolved approximately one month after stent removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCUFLEX PLUS
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16724650
MDR Text Key313143477
Report Number3005099803-2023-01881
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
Reporter Country CodeTH
PMA/PMN Number
K924608
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM006175263010
Device Catalogue Number175-263-01
Device Lot Number0029453171
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2023
Initial Date FDA Received04/12/2023
Supplement Dates Manufacturer Received06/12/2023
Supplement Dates FDA Received07/05/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient SexMale
Patient Weight55 KG
-
-